One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v128.22.98.98
Copy DOI Journal: Blood |  Publication Date: Dec 2, 2016 |
 Citations: 7 |
Affiliation: Sylvester Comprehensive Cancer Center, Stanford Medicine, Colorado Blood Cancer Institute, University of North Carolina at Chapel Hill, Jacksonville College, Mayo Clinic, Winneshiek Medical Center, CHRISTUS Transplant Institute, University of Alabama at Birmingham, Cornell University, Takeda (United States), Millennium Engineering and Integration (United States), Vanderbilt UniversityResults of a Clinical Study of Pevonedistat (Pev), a First-in-Class NEDD8-Activating Enzyme (NAE) Inhibitor, Combined with Azacitidine (Aza) in Older Patients (Pts) with Acute Myeloid Leukemia (AML)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
